Evidence map›Paper›PMID 41088058›Full record

SynthesisBMC cancer2025

The significant prognostic value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score in digestive system cancers: a systematic review and meta-analysis.

Caihua Qian, Jingting Liu, Chunyan Meng, Jun Cheng, Bo Wu, Jianhua Liao

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Prognostic value of the HALP score in patients undergoing emergency surgery for gastroduodenal perforation.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026
    Article
  4. Emergency department evaluation of immature granulocytes for complicated acute appendicitis: a retrospective cohort study.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caihua Qian *Department of Surgery, Zhejiang Hospital, 12 Lingyin Road, Zhejiang, 310013, China.
Jingting Liu *Department of Health management, Sir Run Run Shaw International Medical Centre, 9 Jingtan Road, Hangzhou, Zhejiang, 310000, China.
Chunyan MengDepartment of Surgery, Zhejiang Hospital, 12 Lingyin Road, Zhejiang, 310013, China.
Jun ChengDepartment of Surgery, Zhejiang Hospital, 12 Lingyin Road, Zhejiang, 310013, China.
Bo WuDepartment of Surgery, Zhejiang Hospital, 12 Lingyin Road, Zhejiang, 310013, China.
Jianhua LiaoDepartment of Surgery, Zhejiang Hospital, 12 Lingyin Road, Zhejiang, 310013, China. ljhsywzh@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigestive system cancers are a major global health burden, necessitating reliable and cost-effective prognostic biomarkers for clinical decision-making. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score, an integrated immune-nutrition marker, has emerged as a potential prognostic tool in various malignancies. This meta-analysis evaluated the prognostic value of the HALP score in patients with digestive system cancers.

methodsA systematic search was performed in PubMed, PMC, and Web of Science database for studies assessing HALP scores calculated from pre-treatment blood tests and reporting survival outcomes in patients with digestive system cancers. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled to evaluate the prognostic significance of the HALP score.

resultsA total of 30 articles comprising 34 studies and 9,389 patients were included. High HALP scores were significantly associated with improved survival outcomes. The pooled HR for overall survival (OS) was 1.762 (95% CI: 1.570-1.977, P < 0.001), and similar results were found for disease-free survival (DFS) (HR = 1.841, 95% CI: 1.311-2.585, P < 0.001), recurrence-free survival (RFS) (HR = 1.583, 95% CI: 1.374-1.824, P < 0.001), cancer-specific survival (CSS) (HR = 1.930, 95% CI: 1.590-2.341, P < 0.001), and progression-free survival (PFS) (HR = 1.444, 95% CI: 1.068-1.954, P = 0.017). Subgroup analyses confirmed the robustness of these findings across different treatment strategies and cancer types. Sensitivity and bias analyses (P = 0.103) supported the reliability of these results.

conclusionThe HALP score is a promising prognostic biomarker for digestive system cancers, offering potential for clinical application in personalizing treatment strategies. Future studies should aim to standardize methodologies and validate HALP in prospective multicenter trials.

Indexed as

Biomarkers, TumorBlood PlateletsDigestive System NeoplasmsHemoglobinsLymphocytesSerum AlbuminHumansPlatelet CountPrognosisBiomarkers, TumorHemoglobinsSerum AlbuminDigestive system cancersHALP scoreMeta-analysisPrognostic biomarker

Identifiers

PMID41088058
PMCPMC12523103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.